GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » ROCE %

Halberd (Halberd) ROCE % : 0.00% (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Halberd's annualized ROCE % for the quarter that ended in Jul. 2023 was 0.00%.


Halberd ROCE % Historical Data

The historical data trend for Halberd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd ROCE % Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
ROCE %
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
ROCE % - - -

Halberd ROCE % Calculation

Halberd's annualized ROCE % for the fiscal year that ended in Jul. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2023 )  (A: Jul. 2022 )(A: Jul. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2023 )  (A: Jul. 2022 )(A: Jul. 2023 )
=-0.447/( ( (0.017 - 0.595) + (0.012 - 0.789) )/ 2 )
=-0.447/( (-0.578+-0.777)/ 2 )
=-0.447/-0.6775
=65.98 %

Halberd's ROCE % of for the quarter that ended in Jul. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jul. 2023 )  (Q: Jul. 2022 )(Q: Jul. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jul. 2023 )  (Q: Jul. 2022 )(Q: Jul. 2023 )
=-0.447/( ( (0.017 - 0.595) + (0.012 - 0.789) )/ 2 )
=-0.447/( ( -0.578 + -0.777 )/ 2 )
=-0.447/-0.6775
=0 %

(1) Note: The EBIT data used here is one times the annual (Jul. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd  (OTCPK:HALB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Halberd ROCE % Related Terms

Thank you for viewing the detailed overview of Halberd's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236